[Therapeutic use of phosphatides in retinal diseases. Preliminary communication on the behaviour of visual acuity in macular disease and retinitis pigmentosa].
D000293:Adolescent; D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008266:Macula Lutea; D008297:Male; D008875:Middle Aged; D009902:Optic Neuritis / Q000188:drug therapy; D010743:Phospholipids / Q000494:pharmacology / Q000627:therapeutic use*; D011182:Postoperative Care; D012160:Retina; D012163:Retinal Detachment / Q000601:surgery; D012171:Retinal Vessels / Q000187:drug effects; D012174:Retinitis Pigmentosa / Q000188:drug therapy*; D014020:Tissue Extracts / Q000494:pharmacology / Q000627:therapeutic use; D014792:Visual Acuity / Q000187:drug effects*
D010743:Phospholipids; D014020:Tissue Extracts
Therapeutische Anwendung on Phosphatiden bei retinalen Erkrankungen. Vorläufige Mitteilung über das Verhalten der Sehschärfe bei Maculopathien und Retinigipigmentosa.